Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist
about
Role of cell surface contact in the kinetics of superoxide production by granulocytes.Pharmacological modulation of the effects of N-formyl-L-methionyl-L-leucyl-L-phenylalanine in guinea-pigs: involvement of the arachidonic acid cascade.Leucocyte function in patients with rheumatoid arthritis: quantitative in-vivo leucocyte mobilisation and in-vitro functions of blood and exudate leucocytes.Antiadhesive properties of biological surfaces are protective against stimulated granulocytesHuman neutrophil peptide receptors: mobilization mediated by phospholipase C.Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activationThe Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition.Control of cellular influx in lung and its role in pulmonary toxicology.
P2860
Q28366265-489C1FDC-356E-4058-958C-31C4347BB984Q33446521-34D6ED54-F925-43ED-9096-887254FF0D6EQ33556182-57210E40-B57A-406F-8F44-358FF754A9F5Q34548045-C5B7E90C-547A-4045-B267-57B121308C3CQ35884942-4FC85F7A-2697-4F10-8C29-5FB53DB14E56Q37509006-0A04065D-9554-4D46-A462-3E7CEFEFE7ADQ39196591-33552E9F-FD15-41F0-AC6D-3843175A75FDQ40179987-C32E89D9-EECE-4ED1-94A6-605AE41B9909
P2860
Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
Receptor-directed inhibition o ...... chemotactic peptide antagonist
@en
type
label
Receptor-directed inhibition o ...... chemotactic peptide antagonist
@en
prefLabel
Receptor-directed inhibition o ...... chemotactic peptide antagonist
@en
P2860
P356
P1476
Receptor-directed inhibition o ...... chemotactic peptide antagonist
@en
P2093
P2860
P304
P356
10.1172/JCI109955
P407
P577
1980-11-01T00:00:00Z